4//SEC Filing
Ng George K 4
Accession 0000897069-24-002011
CIK 0001498382other
Filed
Oct 21, 8:00 PM ET
Accepted
Oct 22, 8:47 PM ET
Size
10.1 KB
Accession
0000897069-24-002011
Insider Transaction Report
Form 4
Ng George K
Director
Transactions
- Award
Options (Right to Buy)
2024-10-18+35,780→ 35,780 totalExercise: $2.24From: 2024-10-18Exp: 2030-02-06→ Common Stock (35,780 underlying) - Award
Options (Right to Buy)
2024-10-18+13,553→ 13,553 totalExercise: $3.69From: 2024-10-18Exp: 2033-01-16→ Common Stock (13,553 underlying) - Award
Options (Right to Buy)
2024-10-18+13,553→ 13,553 totalExercise: $4.14From: 2024-10-18Exp: 2034-02-28→ Common Stock (13,553 underlying)
Footnotes (1)
- [F1]Securities issued upon closing of the transactions contemplated by the Agreement and Plan of Merger, dated as of April 2, 2024 (the "Merger Agreement"), among the Issuer (fka "Kintara Therapeutics, Inc."), Kayak Mergeco, Inc., a Delaware corporation and wholly owned subsidiary of Issuer ("Merger Sub"), and TuHURA Biosciences, Inc., a Delaware corporation ("Private TuHURA"). Under the terms of the Merger Agreement, on October 18, 2024, Merger Sub merged with and into Private TuHURA (the "Merger") with Private TuHURA surviving the Merger as a wholly owned subsidiary of the Issuer. Upon the closing of the Merger, securities of Private TuHURA were converted into the right to receive securities of the Issuer as set forth in the Merger Agreement. The Issuer subsequently changed its name to "TuHURA Biosciences, Inc."
Documents
Issuer
Kintara Therapeutics, Inc.
CIK 0001498382
Entity typeother
Related Parties
1- filerCIK 0001638744
Filing Metadata
- Form type
- 4
- Filed
- Oct 21, 8:00 PM ET
- Accepted
- Oct 22, 8:47 PM ET
- Size
- 10.1 KB